Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China · Delayed Price · Currency is CNY 13.70
+0.48 (3.63%)
Apr 30, 2026, 3:04 PM CST
SHE:002365 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 22.49 | 61.77 | -12.31 | 140.35 | 111.42 |
Depreciation & Amortization | 116.68 | 112.83 | 135.18 | 123.62 | 115.96 |
Other Amortization | 0.16 | - | - | - | - |
Loss (Gain) From Sale of Assets | -0.19 | 0.33 | -45.02 | 0.03 | -0.25 |
Asset Writedown & Restructuring Costs | 14.66 | 15.88 | 50.3 | 4.01 | 3.02 |
Loss (Gain) From Sale of Investments | -29.47 | -44.11 | 9.04 | 18.06 | -23.76 |
Provision & Write-off of Bad Debts | -0.09 | -0.69 | -1.61 | -2.47 | 9.74 |
Other Operating Activities | -12.34 | -6.56 | -6.37 | 3.62 | 15.27 |
Change in Accounts Receivable | 39.58 | 36.68 | 18.85 | 163.25 | -172.13 |
Change in Inventory | 3.63 | -25.28 | 87.73 | -10 | -63.66 |
Change in Accounts Payable | -5.21 | -28.19 | -13.08 | -56.54 | 87.17 |
Change in Other Net Operating Assets | - | - | - | 0.94 | 22.52 |
Operating Cash Flow | 139.08 | 105.71 | 221.2 | 387.28 | 101.81 |
Operating Cash Flow Growth | 31.57% | -52.21% | -42.88% | 280.39% | -50.74% |
Capital Expenditures | -62.28 | -118.04 | -120.74 | -149.07 | -63.05 |
Sale of Property, Plant & Equipment | 0.36 | 1.89 | 0.83 | 0.38 | 0.5 |
Cash Acquisitions | - | - | - | - | -35.94 |
Divestitures | - | - | 0.13 | - | - |
Investment in Securities | -86.15 | 33.46 | -91.47 | -108.68 | 101.97 |
Other Investing Activities | 28.01 | 35.31 | 68.27 | 26.98 | 18.34 |
Investing Cash Flow | -120.05 | -47.38 | -142.99 | -230.4 | 21.83 |
Short-Term Debt Issued | 15 | 40.6 | 10 | 60 | 30.8 |
Total Debt Issued | 15 | 40.6 | 10 | 60 | 30.8 |
Short-Term Debt Repaid | -54.5 | -10.5 | -40 | -40 | -145.13 |
Total Debt Repaid | -54.5 | -10.5 | -40 | -40 | -145.13 |
Net Debt Issued (Repaid) | -39.5 | 30.1 | -30 | 20 | -114.33 |
Issuance of Common Stock | 2.5 | - | - | - | 3.04 |
Repurchase of Common Stock | -16.29 | -24.18 | - | - | - |
Common Dividends Paid | -29.88 | -29.82 | -35.77 | -1.57 | -30.74 |
Other Financing Activities | -27 | -13.5 | - | -0.62 | 2.79 |
Financing Cash Flow | -110.17 | -37.4 | -65.77 | 17.81 | -139.25 |
Foreign Exchange Rate Adjustments | 1.32 | 5.25 | 7.08 | 6.51 | -1.08 |
Net Cash Flow | -89.82 | 26.18 | 19.51 | 181.21 | -16.69 |
Free Cash Flow | 76.81 | -12.33 | 100.46 | 238.21 | 38.76 |
Free Cash Flow Growth | - | - | -57.83% | 514.53% | -62.09% |
Free Cash Flow Margin | 9.81% | -1.47% | 10.32% | 16.29% | 2.48% |
Free Cash Flow Per Share | 0.27 | -0.04 | 0.34 | 0.81 | 0.14 |
Cash Interest Paid | - | - | - | - | 0.02 |
Cash Income Tax Paid | 0.07 | 10.13 | -1.97 | 3.19 | 2.48 |
Levered Free Cash Flow | 87.01 | -39.79 | 137.21 | 208.63 | -12.28 |
Unlevered Free Cash Flow | 87.6 | -39.42 | 137.45 | 209.05 | -10.76 |
Change in Working Capital | 27.19 | -33.72 | 91.97 | 100.06 | -129.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.